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Sciences and ChinesAbstract An isocratic RP-HPLC method was developed for the determination of Cefditoren pivoxil
in pharmaceutical formulations using a C-18 column with water–acetonitrile (50:50, v/v) as mobile
phase and ﬂow rate 1.2 mL/min (UV detection at 218 nm). Linearity was observed in the concentration
range 1.0–250 mg/mL (R2¼0.999) with regression equation y¼24194xþ10749. The forced degradation
studies were performed by using HCl, NaOH, and H2O2, and thermal and UV radiation. Cefditoren
pivoxil is more sensitive towards oxidation and alkaline conditions and resistant towards acidic and
photolytic degradations. The method was validated as per ICH guidelines.
& 2012 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Cefditoren pivoxil (Fig. 1) is a third-generation semi-synthetic
cephalosporin antibiotic for oral administration. The therapeutic
potential of Cefditoren has been well documented to include
broad-spectrum effective coverage against both gram-positive and
gram-negative organisms to treat respiratory tract infections [1].
Chemically, Cefditoren pivoxil is (-)-(6R, 7R)-2,2-dimethylpropio-ersity. Production and hosting by E
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tute of Materia Medica, Chinese
e Pharmaceutical Association.nyloxymethyl7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoaceta-
mido]-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabi-
cyclo[4.2.0] oct-2-ene-2-carboxylate with empirical formula
C25H28N6O7S3 and molecular weight 620.73. There are various
methods in literature for the determination of Cefditoren pivoxil in
human plasma [2–4] and in pharmaceutical dosage forms using
HPLC, UPLC and spectrophotometry [5–8] but this method is
selective and speciﬁc. HPLC is the analytical technique that still
dominates the pharmaceutical quality control in the industrial
environment. The aim of this work was to develop a validated
stability indicating HPLC method for the determination of
Cefditoren pivoxil in pharmaceutical dosage forms.2. Experimental
Cefditoren pivoxil standard (purity 99.50%) was obtained
from Cipla Ltd., India. All other chemicals and solvents werelsevier B.V. All rights reserved.
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HPLC grade water was purchased from Qualigens (India).
Cefditoren pivoxil is available as tablets (Label claim: 200 mg)
with brand names SPECTRACEFs (Aristo Pharmaceuticals,
India), CEFTORINs (Cipla Ltd., India) and ZOSTUM-Os
(Zuventus, India). All chemicals were of an analytical grade and
used as received.
Chromatographic separation was achieved by using a C-18
(250 mm 4.6 mm i.d., 5 mm particle size) column of Shi-
madzu Model CBM-20 A/20 Alite, equipped with SPD M20A
prominence photodiode array detector, maintained at 25 1C.
Isocratic elution was performed using acetonitrile and water
(50:50, v/v). The overall run time was 10 min and the ﬂow rate
of the mobile phase was 1.2 mL/min. The wavelength of the
PDA detector was set at 218 nm. 20 mL of sample was injected
into the HPLC system.
Stock solution was prepared by accurately weighing 25 mg
of Cefditoren pivoxil in a 25 mL amber volumetric ﬂask and
making up to volume with mobile phase. Working solutions
for HPLC injections were prepared on a daily basis from the
stock solution in a solvent mixture of acetonitrile and water
(50:50, v/v; mobile phase). Solutions were ﬁltered through a
0.45 mm membrane ﬁlter prior to injection.
Twenty tablets were purchased from the local market,
weighed and crushed to a ﬁne powder. Powder equivalent of
25 mg Cefditoren pivoxil was accurately weighed into a 25 mL
volumetric ﬂask, made up to volume with mobile phase,
sonicated for 30 min and ﬁltered. The ﬁltrate was diluted with
mobile phase as per requirement. The solutions were ﬁltered
through a 0.45 mm nylon ﬁlter before injections.Figure 1 Chemical structure of Cefditoren pivoxil.
Figure 2 Representative chromatograms of Cefditoren pivoxil (100 mg
(C) and ZOSTUM-Os (200 mg) (D).2.1. Forced degradation studies/speciﬁcity
Forced degradation studies were performed to evaluate the
stability indicating properties and speciﬁcity of the method [9].
All solutions for use in stress studies were prepared at an
initial concentration of 1 mg/mL of Cefditoren pivoxil and
reﬂuxed for 30 min at 80 1C in a thermostat and then diluted
with mobile phase to give a ﬁnal concentration of 100 mg/mL.
The acidic and alkaline degradations of Cefditoren pivoxil
in aqueous solutions were studied in hydrochloric acid (0.1 M)
and in sodium hydroxide (0.01 M) at 80 1C and the stressed
samples were instantly cooled with a mixture of ice and water,
neutralized and diluted with mobile phase. Oxidation was
conducted by using 2.0 mL of 30% H2O2 solution whereas
photolysis was performed by exposing the drug solution to
UV (365 nm) for 6 h in a UV light chamber.2.2. Method validation
The method was validated for the following parameters:
system suitability, linearity, limit of quantiﬁcation (LOQ)
and limit of detection (LOD), precision, accuracy, selectivity
and robustness [10].
Linearity test solutions for the assay method were prepared
from a stock solution at different concentration levels of the
assay analyte (1, 5, 10, 20, 50, 100, 150, 200 and 250 mg/mL).
20 mL of each solution was injected into the HPLC system and
the peak area of the chromatogram obtained was noted./mL) (A), SPECTRACEFs (200 mg) (B), CEFTORINs (200 mg)
Table 1 Linearity of Cefditoren pivoxil.
Conc. (mg/mL) aMean area7SD (n¼3) aRSD (%)
1 24224.00751.35 0.21
5 128880.007417.57 0.32
10 240569.007680.81 0.28
20 484027.0072405.61 0.49
50 1252384.0074070.24 0.33
100 2443214.0076694.41 0.27
150 3672705.0075215.24 0.14
200 4844477.00715889.88 0.33
250 6033216.00713695.40 0.23
aMean of three replicates.
M. M. Annapurna et al.468The intra-day and inter-day precision of the assay method
was evaluated at three concentration levels (10, 20 and 50 mg/
mL; n¼3) and the % RSD of three obtained assay values on
three different days was calculated. Standard addition and
recovery experiments were conducted to determine the accu-
racy of the method and the study was carried out in triplicate
at 36, 40 and 44 mg/mL.
The robustness of the assay method was established by
introducing small changes [9] in the HPLC conditions which
included wavelength (216 and 220 nm), percentage of acetoni-Figure 3 Calibration curve of Cefditoren pivoxil.
Table 2 Intra-day and inter-day precision studies of Cefditoren
Sample no. Conc. (mg/mL) Intra-day precision
Meana7SD
1 10 240562.007575.53
2 20 483649.337488.24
3 50 2407203.0077674.96
aMean of three replicates.
Table 3 Accuracy–recovery study of Cefditoren pivoxil by stand
Sample no. Spiked concentration (mg/mL) aMeasured c
1 16 (80%) 15.93
2 20 (100%) 19.87
3 24 (120%) 23.91
aMean of three replicates.
Table 4 Analysis of Cefditoren pivoxil commercial formulation
Sample no. Formulation Labeled claim (m
1 CEFTORINs 200
2 SPECTRACEFs 200
3 ZOSTUM-Os 200
aMean of three replicates.trile in the mobile phase (48% and 52%) and ﬂow rate (1.1
and 1.3 mL/min). Robustness of the method was studied using
six replicates at a concentration level of 20 mg/mL of Cefdi-
toren pivoxil.3. Results and discussion
The present method is a stability indicating RP-HPLC method
which was not reported earlier and also speciﬁc because the
drug peak was well separated even in the presence of
degradation products. The representative chromatogram
obtained for the drug is shown in Fig. 2A. The representativepivoxil.
Inter-day precision
RSD (%) Meana7SD aRSD (%)
0.24 240160.3071210.88 0.50
0.10 484082.3072122.54 0.44
0.32 2398627.00713779.59 0.58
ard-addition method.
oncentration (mg/mL) Recoverya (%) aRSD (%)
99.56 0.1424
99.35
99.62
(tablets).
g) aAmount found (mg) aRecovery (%)
198.96 99.48
199.23 99.62
199.64 99.82
Figure 4 Representative chromatograms of Cefditoren pivoxil
(100 mg/mL) on alkaline (A), oxidative (B), acidic (C), thermal (D)
and photolytic (E) degradations.
Table 5 Forced degradation studies of Cefditoren pivoxil.
Stress conditions aDrug recovered (%) aDrug decomposed (%)
Standard drug 100.00 –
Acidic hydrolysis 91.46 8.54
Alkaline hydrolysis 68.17 31.83
Oxidative degradation 36.28 63.72
Thermal degradation 99.91 0.09
Photolytic degradation 99.95 0.05
aMean of three replicates.
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extracted marketed formulations are shown in Fig. 2B–D.
Linearity was evaluated in the concentration range 1.0–
250 mg/mL (Table 1). The calibration curve (Fig. 3) was
described by the equation, y¼24194xþ10749 with correlation
coefﬁcient 0.999 and RSD less than 0.5% (0.142–0.497). The
% RSD in precision (Table 2), accuracy (Table 3) and
robustness studies was found to be less than 2.0%, indicating
that the method is precise, accurate and robust. The LOD and
LOQ were found to be 0.2093 and 0.6351 mg/mL respectively.
The assay results obtained from the marketed formulations
are given in Table 4. The capacity factor was more than 2,
theoretical plates were 8476 (more than 2000) and tailing
factor was 1.12 (less than 2) for the Cefditoren pivoxil peak.
Typical chromatograms obtained following the assay of
stressed samples are shown in Fig. 4A–E. Cefditoren pivoxil
shows signiﬁcant degradation in alkaline hydrolysis and
oxidative stress conditions. 31.83% of Cefditoren pivoxil was
degraded in alkaline conditions with an extra peak at
1.816 min and this may be due to the presence of the
aminothiazol-4-yl-2-methoxyiminoacetamido moiety present
in the chemical structure. Cefditoren pivoxil was also very
much sensitive to oxidative conditions as 63.72% was decom-
posed (Table 5).4. Conclusion
This stability-indicating and validated HPLC method is pre-
cise, accurate and robust, can be applied for the determination
of Cefditoren pivoxil in pharmaceutical dosage forms.
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